GeLongHui October 30th| Zhejiang Hisun Pharmaceutical (600267.SH) released its third-quarter report, with revenue for the first three quarters at 7.87 billion yuan, a 9.50% decrease year-on-year. Net income was 0.515 billion yuan, a 16.49% year-on-year increase. Non-GAAP net income was 0.346 billion yuan, an 8.80% year-on-year increase, with basic earnings per share of 0.44 yuan.
海正药业(600267.SH)：前三季净利润5.15亿元 同比增长16.49%
Zhejiang Hisun Pharmaceutical (600267.SH): The net income for the first three quarters was 0.515 billion yuan, a year-on-year increase of 16.49%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Investment Course
Choose stocks based on financial reports
Quickly master financial season learning guidelines
When the financial season comes, company stock prices are the most likely to rise and fall, and many excellent investors will see the financial season as a good
How to view Tesla's performance in January 2025? Pay attention to these four key points.
It's earnings season for US stocks again. The performance of giant companies not only affects their own stock prices but also influences the overall trend of th
In 【2024.11】, surged more than 0.04 million times, achieving the title of stock god Buffett! How do you view Berkshire's performance?
When it comes to legendary figures in the investment world, the name of Warren Buffett, the helm of Berkshire Hathaway, is definitely unavoidable. $Berkshire Ha